Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Oct 15, 2014; 6(10): 407-412
Published online Oct 15, 2014. doi: 10.4251/wjgo.v6.i10.407
Published online Oct 15, 2014. doi: 10.4251/wjgo.v6.i10.407
Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview
Alvaro Arjona-Sánchez, Francisco Javier Medina-Fernández, Francisco Cristobal Muñoz-Casares, Angela Casado-Adam, Juan Manuel Sánchez-Hidalgo, Sebastián Rufián-Peña, Unit of Oncological and Pancreatic Surgery, Department of General and Digestive Surgery, University Hospital Reina Sofia, 14004 Cordoba, Spain
Author contributions: All authors contributed to this paper.
Correspondence to: Dr. Alvaro Arjona-Sánchez, Unit of Oncological and Pancreatic Surgery, Department of General and Digestive Surgery, University Hospital Reina Sofia, Avda.Menéndez Pidal s/n, 14004 Córdoba, Spain. alvaroarjona@hotmail.com
Telephone: +34-95-7010439 Fax: +34-95-7010949
Received: November 30, 2013
Revised: April 17, 2014
Accepted: September 16, 2014
Published online: October 15, 2014
Processing time: 324 Days and 6.9 Hours
Revised: April 17, 2014
Accepted: September 16, 2014
Published online: October 15, 2014
Processing time: 324 Days and 6.9 Hours
Core Tip
Core tip: The carcinomatosis peritoneal from colon origin has turned from a terminal condition to a curative scenery. The cytoreduction and peritonectomy procedures with hyperthermic intraperitoneal chemotherapy have achieved 50% in 5 years overall survival, with a low morbidity that is not higher than other major surgical procedures.